CIENCIASMEDICASNEWS: Flow Imaging Microscopy: Comparing FlowCam with MFI

viernes, 2 de octubre de 2020

Flow Imaging Microscopy: Comparing FlowCam with MFI

	Drug Discovery and Production
	The latest drug discovery news from News Medical

Monitoring Ambient Environmental Conditions in the Lab

Flow Imaging Microscopy: Comparing FlowCam with MFI

The FDA strongly recommends in-depth characterization of particles in protein therapeutics. Flow Imaging Microscopy is increasingly being utilized because it can provide incredible insight into your formulation, allowing you to see your particles like never before. Learn why MFI is being replaced by FlowCam in leading laboratories around the world as the Flow Imaging Microscopy instrument of choice.

See the Specifications

Coronavirus (COVID-19) Sample Tracking Packages

To satisfy the huge global demand for proven technological solutions to assist labs involved with the essential RT-PCR assay part of the “test, trace and isolate” strategy for dealing with the SARS-CoV-2 virus pandemic – Ziath is offering two optimized packages for reliable tracking of patient samples submitted for Coronavirus testing.

Learn More

Rotary Evaporators: An Innovative Approach to their Design

In most organic chemistry and pharmaceutical labs, rotovaps are used so frequently that each lab member will often have their own machine. Because they are so heavily used and relied upon, any innovation resulting in faster, more energy-efficient, or more convenient rotovaps will likely have major payoffs for both lab productivity and environmental sustainability.

	What is Epitranscriptomics? The epitranscriptome is the collection of biochemical modifications of the RNA transcripts present in a cell.

	Helping Identify Novel Psychoactive Substances The last few years have witnessed an exponential increase in the use of novel psychoactive substances (NPS).

	How do hallucinogenic drugs exert their actions on the brain? Not much is known about the fundamental mechanisms in the brain of hallucinogenic drugs and the way they induce their hallucinogenic effects.

	Researchers develop antibacterial agent to treat drug-resistant infections Methicillin-resistant Staphylococcus aureus (MRSA) is the most lethal drug-resistant bacteria and is also one of the most common bacterial pathogens.